About the Organization We are a U.S.-headquartered global biopharmaceutical platform advancing next-generation biologics and specialty therapeutics across high-complexity, regulated manufacturing environments. Our portfolio includes late-stage and commercial programs supported by internal GMP capabilities and a global CDMO/CMO partner ecosystem spanning drug substance, drug product, packaging/labeling, and cold-chain distribution. Operating at the intersection of clinical velocity, […]